Life Science Compliance Update

« Previous article | Home| Next article »

July 29, 2016

The Olympus Settlement – What It Can Tell Us About the Compliance Officer


When dissecting recent settlements, we normally look at the underlying events and process failures. The recent Olympus settlement, however, provides us a rare glimpse into the nature of the Compliance Officer himself and how that can affect matters.

In March, we reported that medical equipment giant Olympus Corp. of the Americas (OCA) and its Miami- based subsidiary Olympus Latin America (OLA) had reached a settlement with the Department of Justice to pay a combined $646 million in civil awards and criminal penalties to the federal and various state governments, and reform its compliance program. The settlement is the largest ever for a medical device manufacturer accused of violating the Anti-Kickback Statute.

Read Full Article in the July 2016 Issue of Life Science Compliance Update

To Read the Full Story, Subscribe, Download a Sample Issue, or Sign In

« Previous article | Home| Next article »


Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.


Preview | Powered by FeedBlitz


April 2018
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30